Approximately 25% of all individuals infected with HIV are coinfected with HCV.1 Of critical significance, HIV increases the rate of progression of HCV-related hepatic fibrosis, and HCV is associated with a 3-fold increase in HIV antiretroviral therapy (ART)–induced liver toxicity.2 Further, these synergistic diseases often occur within adverse socioeconomic conditions that significantly increase the vulnerability and decrease the overall health status of at-risk populations.3 Whereas HIV infection is now effectively manageable, chronic HCV infection is curable. Yet, despite new, highly effective direct-acting antiviral (DAA) treatment regimens for HCV, their broad-scale use and associated therapeutic successes remain stymied by barriers at the patient, clinician, health care system, and jurisdictional levels.4 The BLOCK HIV/HCV initiative will provide community-based infectious disease specialists and other HIV treaters with foundational information and practical resources needed to prepare local stakeholders—both clinical and nonclinical—to collaborate in efforts to eliminate HCV within their communities.
After completing this activity, the participant should be better able to:
This activity is intended for a multidisciplinary audience including community-based infectious disease specialists and other human immunodeficiency virus (HIV) treaters, gastroenterology/hepatology clinicians, mental health specialists, substance abuse specialists, correctional health care professionals, public policy/public health officials, hepatitis C virus (HCV) and HIV advocacy groups, payers, and clinical office staff who are engaged in the care of patients with HIV and/or HCV.
10 minutes - Welcome and Preactivity Polling
30 minutes - The Challenge of HCV Elimination
30 minutes - HCV Therapy: The State of the Union
20 minutes - Populations in Greatest Need—Men Who Have Sex With Men (MSM)
20 minutes - BREAK
30 minutes - Populations in Greatest Need—People Who Inject Drugs (PWID)
20 minutes - Other Real-World Circumstances
20 minutes - Success Stories
30 minutes - LUNCH
30 minutes - Addressing Region-Specific Barriers and Challenges to HCV Elimination
10 minutes - Introduction to Small-Group Breakouts: Bringing Together Stakeholders and Creating a Collaborative Plan
30 minutes - Multidisciplinary Small Groups: Putting a Plan Into Action
60 minutes - Panel Discussion: The Call to Action & Beyond
20 minutes - Closing Statements & Postactivity Polling
There is no fee to register for this activty.
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Integritas Communications. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Postgraduate Institute for Medicine designates this continuing education activity for 5.0 contact hours (0.50 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - JA4008162-9999-18-003-L01-P)
Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service.
The maximum number of hours awarded for this Continuing Nursing Education activity is 5.1 contact hours.
Pharmacotherapy contact hours for Advanced Practice Registered Nurses to be determined.
Social Workers and Case Manager credit will be applied for, but is not guaranteed at this time.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are positioned to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Nora Eldasher prior to the live event at email@example.com.
There is no fee for this educational activity.
For more information on the BLOCK HIV/HCV initiative, please visit: www.blockhivhcv.com